Author response for 'Effects of Once‐Weekly Subcutaneous Semaglutide on Coronary Artery Disease Outcomes in Patients with Type 2 Diabetes with or at High Risk for Cardiovascular Disease: Insights from the SUSTAIN‐6 Trial'

Autor:	null Ahmed A. Kolkailah, null Ildiko Lingvay, null Idit Dobrecky‐Mery, null Alona Aharonovich, null Jens‐Peter David, null Cecilie Holse, null Søren Rasmussen, null Darren K. McGuire
Rok vydání:	2022
DOI:	10.1111/dom.14941/v2/response1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2476148a7ebc3e91d364910c3dcfe72e https://doi.org/10.1111/dom.14941/v2/response1 Zobrazit plný text záznamu